Modifying the uses, disclosure, and requirement dates of prescription drug price transparency data. Modifies reporting timelines of prescription drug price data for health carriers, drug manufacturers, pharmacy benefit managers, and pharmacy service administration
organizations. Allows the Health Care Authority to publish certain price increase data submitted by prescription drug manufacturers.
Allows the Office of the Governor, the Office of the Attorney General, and legislative committees to obtain submitted prescription drug price data through a nondisclosure agreement.